<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pulmo-2817</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Десятилетний опыт молекулярногенетической диагностики муковисцидоза в МГНЦ РАМН</article-title><trans-title-group xml:lang="en"><trans-title>Ten years of molecular genetic diagnosis of cystic fibrosis in Russian patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гинтер</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Ginter</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Медико-генетический центр РАМН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2001</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2001</year></pub-date><volume>0</volume><issue>3</issue><fpage>17</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петрова Н.В., Гинтер Е.К., 2001</copyright-statement><copyright-year>2001</copyright-year><copyright-holder xml:lang="ru">Петрова Н.В., Гинтер Е.К.</copyright-holder><copyright-holder xml:lang="en">Petrova N.V., Ginter E.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/2817">https://journal.pulmonology.ru/pulm/article/view/2817</self-uri><abstract><p>Молекулярно-генетическое исследование больных муковисцидозом (МВ) проводится в лаборатории генетической эпидемиологии МГНЦ РАМН с 1990 г. К настоящему времени молекулярно-генетический анализ выполнен в 466 семьях, имеющих больного МВ ребенка. Предварительное клиническое обследование и постановка диагноза проводились в научно-клиническом отделении муковисцидоза МГНЦ РАНМ. Более 80% пациентов проживали в Европейской части России, около 15% – из районов Сибири и Дальнего Востока. ДНК больных и их родителей проскринировали на 17 мутаций в гене CFTR. Относительные частоты 13 обнаруженных мутаций следующие: ∆Р508 – 53%, CFTRdele2,3(21кЬ) – 6,4%, N1303К – 2,6%, G542Х – 2,0%, W1282Х – 1,9%, 3849+10кbС-Т – 1,9%, 2143∆Т – 1,8%, 2184insА – 1,8%, R334W – 0,7%, S1196Х – 0,7%, 1677∆ТА – 0,5%, 394∆ТТ – 0,4%, G551D – 0,3%. Кажется вероятным, что возможно выделить ядро частых “славянских” мутаций в изученной выборке МВ хромосом: СFTRdele2,3(21кЬ), 2143∆Т, 2184insA, но их происхождение и история распространения требуют дальнейшего исследования и уточнения. Примерно в 25% муковисцидозных хромосомах мутация остается неидентифицированной, поэтому в семьях, где один или оба родителя являются носителями неидентифицированных мутаций, проводится анализ внутри- и внегенных ДНК-маркеров для определения фазы сцепления мутантного МВ-аллеля. В результате информативность косвенного теста в семьях, имеющих больного МВ ребенка, достигает 100%.</p></abstract><trans-abstract xml:lang="en"><p>Since 1990 466 OF patients and more than 1000 members of their families which were clinically diagnosed in the Department of OF of the Research Centre for Medical Genetics have been examined for 20 mutations in the CFTR gene. More than 80% of the patients were originated from the European part of Russia. The relative frequencies of 13 screened OF mutations were as follows: AF508 — 53%, CFTkdele2.3(21kb) – 6.4%, N1303K – 2.6%, G542X – 2.0%, W1282X – 1.9%, – 3849+1 OkbC-T – 1.9%, 2143AT – 1.8%, 2184insA – 1,8%, R334W – 0.7%, S1196X – 0.7%, 394ATT – 0.4%, 1677ATA – 0.5%, G551D – 0.3%. Other screened mutations have not been identified in our sample. The above mentioned 13 mutations account for 75% of all OF alleles of Russian patients. It seems that it is possible to distinguish a nucleos of common “Slavic” mutations (CFTRdele2.3(21kb), 2143AT, 21S4insA) but their origin and history of distribution should be clarified further. Still about 25% of OF alleles are remained to be identified in Russian- population and only for 56% of OF patients the full OF genotype could be recognized. In families where one or both parents have unidentified mutations analysis of inter- andintragenic DNA markers have been exploited to complete genetic testing. As a result the informativity close to 100% could be obtained for all families with the OF child.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Riordan J.R., Rommens J.M., Кегет В.Sh. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066—1073.</mixed-citation><mixed-citation xml:lang="en">Riordan J.R., Rommens J.M., Кегет В.Sh. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066—1073.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">The Cystic Fibrosis Genetic Analysis Consortium. Population variation of common cystic fibrosis mutations. Hum. Mutat. 1994; 4: 167—177.</mixed-citation><mixed-citation xml:lang="en">The Cystic Fibrosis Genetic Analysis Consortium. Population variation of common cystic fibrosis mutations. Hum. Mutat. 1994; 4: 167—177.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Verlinguer C., Kapranov N.I., Mercier B. et al. Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel allels. Hum. Mutat. 1995; 113: 205—209.</mixed-citation><mixed-citation xml:lang="en">Verlinguer C., Kapranov N.I., Mercier B. et al. Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel allels. Hum. Mutat. 1995; 113: 205—209.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Morral N., Nunes V., Casals T. et al. Uniparenteral inheritance of microsatellite allerts of the cystic fibrosis gene (CFTR): identification of a 50 kilobase deletion. Hum. Mol. Genet. 1993; 2: 677—681.</mixed-citation><mixed-citation xml:lang="en">Morral N., Nunes V., Casals T. et al. Uniparenteral inheritance of microsatellite allerts of the cystic fibrosis gene (CFTR): identification of a 50 kilobase deletion. Hum. Mol. Genet. 1993; 2: 677—681.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Magnani C., Cremonesi L., Giunta A. et al. Short direct repeats at the breakpoints of a novel large deletion in the CFTR gene suggest a likely slipped mispairing mechanism. Hum. Genet. 1996; 98: 102—108.</mixed-citation><mixed-citation xml:lang="en">Magnani C., Cremonesi L., Giunta A. et al. Short direct repeats at the breakpoints of a novel large deletion in the CFTR gene suggest a likely slipped mispairing mechanism. Hum. Genet. 1996; 98: 102—108.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chevalier-Porst F., Bonardot A.M., Chazalette J.P. et al. 40Kilobase deletion (CF44dele4-10) removes exons 4-10 of the cystic fibrosis transmembrane conductance regulator gene. Hum. Mutat. 1998; suppl.l: 291—294.</mixed-citation><mixed-citation xml:lang="en">Chevalier-Porst F., Bonardot A.M., Chazalette J.P. et al. 40Kilobase deletion (CF44dele4-10) removes exons 4-10 of the cystic fibrosis transmembrane conductance regulator gene. Hum. Mutat. 1998; suppl.l: 291—294.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mickle J.E., Macek M.Jr., Fulmer-Smentek S. et al. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum. Mol. Genet. 1998; 7:729—735.</mixed-citation><mixed-citation xml:lang="en">Mickle J.E., Macek M.Jr., Fulmer-Smentek S. et al. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum. Mol. Genet. 1998; 7:729—735.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lerer I., Laufer-Cahana A., Rivlin J.R. et al. A large deletion mutation in the CFTR gene (3120+1 kbdel8, 6kb): a founder mutation in the Palestinian Arabs. Hum. Mutat. 1999; 13: 337.</mixed-citation><mixed-citation xml:lang="en">Lerer I., Laufer-Cahana A., Rivlin J.R. et al. A large deletion mutation in the CFTR gene (3120+1 kbdel8, 6kb): a founder mutation in the Palestinian Arabs. Hum. Mutat. 1999; 13: 337.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dork Т., Macek M.Jr., Mekus F. et al. Characterization of a novel 21-kb deletion, CFTRdele2,3(21kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum. Genet. 2000; 106: 259—268.</mixed-citation><mixed-citation xml:lang="en">Dork Т., Macek M.Jr., Mekus F. et al. Characterization of a novel 21-kb deletion, CFTRdele2,3(21kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum. Genet. 2000; 106: 259—268.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
